Literature DB >> 15504884

Antimicrobial susceptibility patterns among viridans group streptococcal isolates from infective endocarditis patients from 1971 to 1986 and 1994 to 2002.

Rajesh M Prabhu1, Kerryl E Piper, Larry M Baddour, James M Steckelberg, Walter R Wilson, Robin Patel.   

Abstract

To determine whether changes in antimicrobial resistance have occurred among viridans group streptococci, we retrospectively examined 50 viridans group streptococcal isolates recovered from patients with infective endocarditis over 3 decades. Resistance rates (percent resistant isolates 1971 to 1986 and 1994 to 2002) were as follows: levofloxacin, 0 and 9; penicillin and clindamycin, 0 and 4; and erythromycin and azithromycin, 11 and 26, respectively.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15504884      PMCID： PMC525427          DOI： 10.1128/AAC.48.11.4463-4465.2004

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  25 in total

1.  Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and cefotaxime.

Authors:  J R Lonks; B P Dickinson; V Runarsdottir
Journal:  N Engl J Med       Date:  1999-10-14       Impact factor: 91.245

2.  Endocarditis due to Streptococcus mitis with high-level resistance to penicillin and ceftriaxone.

Authors:  C Sabella; D Murphy; J Drummond-Webb
Journal:  JAMA       Date:  2001-05-02       Impact factor: 56.272

3.  In vitro activities of fluoroquinolones against antibiotic-resistant blood culture isolates of viridans group streptococci from across Canada.

Authors:  J C de Azavedo; L Trpeski; S Pong-Porter; S Matsumura; D E Low
Journal:  Antimicrob Agents Chemother       Date:  1999-09       Impact factor: 5.191

4.  Increased incidence of bacteraemia due to viridans streptococci in an unselected population of patients with acute myeloid leukaemia.

Authors:  L Persson; T Vikerfors; L Sjöberg; P Engervall; U Tidefelt
Journal:  Scand J Infect Dis       Date:  2000

5.  Activities of new fluoroquinolones, ketolides, and other antimicrobials against blood culture isolates of viridans group streptococci from across Canada, 2000.

Authors:  Andrea S Gershon; Joyce C S de Azavedo; Allison McGeer; Krystyna I Ostrowska; Deirdre Church; Daryl J Hoban; Godfrey K M Harding; Karl Weiss; Lewis Abbott; Fiona Smaill; Marie Gourdeau; Gilles Murray; Donald E Low
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

6.  The influence of antimicrobial prophylaxis on the microbial and clinical findings in patients after autologous bone marrow transplantation.

Authors:  V Haahr; N A Peterslund; J K Møller
Journal:  Scand J Infect Dis       Date:  1997

7.  Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America.

Authors:  D J Diekema; M L Beach; M A Pfaller; R N Jones
Journal:  Clin Microbiol Infect       Date:  2001-03       Impact factor: 8.067

Review 8.  Endocarditis caused by penicillin-resistant viridans streptococci: 2 cases and controversies in therapy.

Authors:  C S Levy; P Kogulan; V J Gill; M B Croxton; J G Kane; D R Lucey
Journal:  Clin Infect Dis       Date:  2001-07-06       Impact factor: 9.079

9.  Trovafloxacin treatment of viridans group Streptococcus experimental endocarditis.

Authors:  K E Piper; M S Rouse; K L Ronningen; J M Steckelberg; W R Wilson; R Patel
Journal:  Antimicrob Agents Chemother       Date:  2000-09       Impact factor: 5.191

10.  Antimicrobial susceptibility of viridans group streptococci in Taiwan with an emphasis on the high rates of resistance to penicillin and macrolides in Streptococcus oralis.

Authors:  L J Teng; P R Hsueh; Y C Chen; S W Ho; K T Luh
Journal:  J Antimicrob Chemother       Date:  1998-06       Impact factor: 5.790
View more
  16 in total

1.  Incidence of infective endocarditis caused by viridans group streptococci before and after publication of the 2007 American Heart Association's endocarditis prevention guidelines.

Authors:  Daniel C Desimone; Imad M Tleyjeh; Daniel D Correa de Sa; Nandan S Anavekar; Brian D Lahr; Muhammad R Sohail; James M Steckelberg; Walter R Wilson; Larry M Baddour
Journal:  Circulation       Date:  2012-06-11       Impact factor: 29.690

2.  Mutations in cdsA and pgsA Correlate with Daptomycin Resistance in Streptococcus mitis and S. oralis.

Authors:  Truc T Tran; Nagendra N Mishra; Ravin Seepersaud; Lorena Diaz; Rafael Rios; An Q Dinh; Cristina Garcia-de-la-Maria; Michael J Rybak; Jose M Miro; Samuel A Shelburne; Paul M Sullam; Arnold S Bayer; Cesar A Arias
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

3.  Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis.

Authors:  C Garcia-de-la-Maria; Y Q Xiong; J M Pericas; Y Armero; A Moreno; N N Mishra; M J Rybak; T T Tran; C A Arias; P M Sullam; A S Bayer; J M Miro
Journal:  Antimicrob Agents Chemother       Date:  2017-04-24       Impact factor: 5.191

4.  Dentistry and Endocarditis.

Authors:  Michael J Wahl; Thomas J Pallasch
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

5.  Phylogenetic analysis of viridans group streptococci causing endocarditis.

Authors:  Keith E Simmon; Lori Hall; Christopher W Woods; Francesc Marco; Jose M Miro; Christopher Cabell; Bruno Hoen; Mercedes Marin; Riccardo Utili; Efthymia Giannitsioti; Thanh Doco-Lecompte; Suzanne Bradley; Stanley Mirrett; Arjana Tambic; Suzanne Ryan; David Gordon; Phillip Jones; Tony Korman; Dannah Wray; L Barth Reller; Marie-Francoise Tripodi; Patrick Plesiat; Arthur J Morris; Selwyn Lang; David R Murdoch; Cathy A Petti
Journal:  J Clin Microbiol       Date:  2008-07-23       Impact factor: 5.948

6.  Garenoxacin treatment of experimental endocarditis caused by viridans group streptococci.

Authors:  Paloma Anguita-Alonso; Mark S Rouse; Kerryl E Piper; James M Steckelberg; Robin Patel
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

7.  Perturbations of Phosphatidate Cytidylyltransferase (CdsA) Mediate Daptomycin Resistance in Streptococcus mitis/oralis by a Novel Mechanism.

Authors:  Nagendra N Mishra; Truc T Tran; Ravin Seepersaud; Cristina Garcia-de-la-Maria; Kym Faull; Alex Yoon; Richard Proctor; Jose M Miro; Michael J Rybak; Arnold S Bayer; Cesar A Arias; Paul M Sullam
Journal:  Antimicrob Agents Chemother       Date:  2017-03-24       Impact factor: 5.191

8.  Clinical features and antimicrobial susceptibility of oral bacteria isolated from the blood cultures of patients with infective endocarditis.

Authors:  Keigo Maeda; Yuzo Hirai; Masanori Nashi; Shinsuke Yamamoto; Naoki Taniike; Toshihiko Takenobu
Journal:  J Dent Sci       Date:  2021-09-28       Impact factor: 3.719

9.  Pharmacokinetics of Penicillin G in Preterm and Term Neonates.

Authors:  Helgi Padari; Tuuli Metsvaht; Eva Germovsek; Charlotte I Barker; Karin Kipper; Koit Herodes; Joseph F Standing; Kersti Oselin; Tõnis Tasa; Hiie Soeorg; Irja Lutsar
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

10.  Drug susceptibility testing of clinical isolates of streptococci and enterococci by the Phoenix automated microbiology system.

Authors:  Gioconda R Brigante; Francesco A Luzzaro; Beatrice Pini; Gianluigi Lombardi; Gertrude Sokeng; Antonio Q Toniolo
Journal:  BMC Microbiol       Date:  2007-05-23       Impact factor: 3.605
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.